DOI: 10.1007/s00259-017-3648-xPages: 1092-1094

Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?

1. Tata Memorial Centre Annexe, Radiation Medicine Centre, Bhabha Atomic Research Centre

Correspondence to:
Sandip Basu
Tel: 91 22 24149428
Email: drsanb@yahoo.com

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: Feb 7, 2017
  • Online: Feb 24, 2017

Article Tools

eanm
EJNMMI Ad